Schmitz Patrick 4
4 · NEVRO CORP · Filed Mar 3, 2020
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Schmitz Patrick
Vice President, Operations
Transactions
- Exercise/Conversion
Common Stock
2020-02-28$42.30/sh+5,156$218,099→ 61,542 total - Sale
Common Stock
2020-02-28$126.47/sh−4,604$582,265→ 56,938 total - Sale
Common Stock
2020-02-28$130.82/sh−600$78,495→ 18,658 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-28−7,312→ 5,688 totalExercise: $76.81Exp: 2027-11-13→ Common Stock (7,312 underlying) - Exercise/Conversion
Common Stock
2020-02-28$87.62/sh+10,833$949,187→ 49,074 total - Exercise/Conversion
Common Stock
2020-02-28$76.81/sh+7,312$561,635→ 56,386 total - Sale
Common Stock
2020-02-28$127.06/sh−7,404$940,773→ 49,534 total - Sale
Common Stock
2020-02-28$128.25/sh−2,758$353,722→ 46,776 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-28−5,156→ 11,344 totalExercise: $42.30Exp: 2028-11-26→ Common Stock (5,156 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-28−19,583→ 417 totalExercise: $57.89Exp: 2026-03-13→ Common Stock (19,583 underlying) - Exercise/Conversion
Common Stock
2020-02-28$57.89/sh+19,583$1,133,660→ 38,241 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-28−10,833→ 2,500 totalExercise: $87.62Exp: 2026-11-15→ Common Stock (10,833 underlying) - Sale
Common Stock
2020-02-28$129.34/sh−17,205$2,225,262→ 29,571 total - Sale
Common Stock
2020-02-28$130.13/sh−10,313$1,342,058→ 19,258 total
Footnotes (12)
- [F1]Includes 11,397 restricted stock units.
- [F10]1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2016 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F11]1/48th of the shares subject to the option vest on each monthly anniversary measured from November 14, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F12]1/48th of the shares subject to the option vest on each monthly anniversary measured from November 27, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $125.69 to $126.685, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $126.695 to $127.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $127.70 to $128.695, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $128.71 to $129.705, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $130.74 to $130.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F9]25% of the shares subject to the option vest on the first anniversary measured from March 14, 2016 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.